harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products.
Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers.
In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany.
Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.
2019
Served areaWorldwide
Headcount66
HeadquartersLochhamer Schlag 21, 82166 Gräfelfing – Germany
Date | Trading entity / Person | Association | Trade type | Volume | Average price |
---|---|---|---|---|---|
05.10.22 | MMI Leisure & Capital Management GmbH | Close relation | Buy | 125,383.20 € | 05.10.22 |
05.10.22 | MMI Leisure & Capital Management GmbH | Close relation | Buy | 26.60 € | 05.10.22 |
05.10.22 | Hillen, Ingo | Board | Buy | 1,048.00 € | 05.10.22 |
30.05.22 | Simon-Schröter, Dr. Wolfram | Other | Buy | 10,040.00 € | 30.05.22 |
30.05.22 | Schröter, Jasmin | Close relation | Buy | 119,660.00 € | 30.05.22 |
30.05.22 | Wittig, Dr. Thomas | Supervisory board | Buy | 138,953.80 € | 30.05.22 |
25.04.22 | Bloching, Prof. Dr. Micha | Supervisory board | Sell | 171,825.00 € | 25.04.22 |
25.04.22 | MMI Leisure & Capital Management GmbH | Close relation | Sell | 99.00 € | 25.04.22 |
25.04.22 | MMI Leisure & Capital Management GmbH | Close relation | Sell | 197,193.60 € | 25.04.22 |
25.04.22 | FUTRUE GmbH | Close relation | Buy | 208,180.53 € | 25.04.22 |
07.12.21 | FUTRUE GmbH | Close relation | Buy | 550,800.00 € | 07.12.21 |
07.12.21 | MVH Beteiligungs- und Beratungs-GmbH | Close relation | Buy | 63,750.00 € | 07.12.21 |
02.12.21 | FUTRUE GmbH | Close relation | Buy | 5,508,000.00 € | 02.12.21 |
02.12.21 | MVH Beteiligungs- und Beratungs-GmbH | Close relation | Buy | 612,000.00 € | 02.12.21 |
20.10.21 | Laik, Robin | Board | Other | 2.66 € | 20.10.21 |
19.10.21 | Günther, Bernd | Supervisory board | Buy | 89.60 € | 19.10.21 |
18.10.21 | Ceccaldi, Julie | Close relation | Sell | 6,267.50 € | 18.10.21 |
18.10.21 | MVH Beteiligungs- und Beratungs-GmbH | Close relation | Buy | 1,018,517.50 € | 18.10.21 |
18.10.21 | FUTRUE GmbH | Close relation | Buy | 9,667,157.50 € | 18.10.21 |
13.10.21 | Zeitfracht GmbH & Co. KGaA | Close relation | Sell | 61,610.00 € | 13.10.21 |
13.10.21 | Müller, Dr. Axel | Supervisory board | Other | 4,714.50 € | 13.10.21 |
12.10.21 | FUTRUE GmbH | Close relation | Buy | 1,743,861.20 € | 12.10.21 |
12.10.21 | Zeitfracht GmbH & Co. KGaA | Close relation | Sell | 64,640.00 € | 12.10.21 |
05.10.21 | Horch, Johann | Board | Buy | 7,519.48 € | 05.10.21 |
07.07.21 | MVH Beteiligungs- und Beratungs-GmbH | Close relation | Buy | 754,425.00 € | 07.07.21 |
07.07.21 | FUTRUE GmbH | Close relation | Buy | 6,789,825.00 € | 07.07.21 |
01.07.21 | Sultzer, Marcus | Board | Other | 499,966.00 € | 01.07.21 |
01.07.21 | Weick, Achim | Board | Other | 76,000.00 € | 01.07.21 |
01.07.21 | Vogel, Rony | Supervisory board | Other | 114,000.00 € | 01.07.21 |
28.06.21 | MVH Beteiligungs- und Beratungs-GmbH | Close relation | Buy | 716,750.00 € | 28.06.21 |
28.06.21 | FUTRUE GmbH | Close relation | Buy | 6,450,750.00 € | 28.06.21 |
12,000,000
IPOJune 19, 2020
Designated Sponsor(s)Joh. Berenberg, Gossler & Co. KG
Stock exchange(s)Frankfurt Stock Exchange